| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |